Kevzara Fails COVID-19 Patients for the Last Time

Sanofi and Regeneron reported a phase 3 failure with their rheumatoid arthritis treatment and severely affected COVID-19 patients. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.